We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/6/2018 10:03 | Any specific reason for issuing a RNS regarding total voting rights today? Don't know the regulations here, genuinely asking. Might it be related to a soon to be expected takeover offer (in shares)? | greedfear | |
28/6/2018 15:00 | Price looking perky again today. Probably no coincidence that it has come back to the upward trend line. My opinion is that the sum of the parts including whatever cash is left has got to be worth more than £35 million! | nobbygnome | |
27/6/2018 18:04 | Disciplined investment is good. Not always worth the risk which is still present at this stage. Hard to say for sure whether a good deal would go through but downside risks seems minimised. | compoundinge | |
27/6/2018 17:47 | Thanks for sharing Timbo. 200 mil potential milestone payments + mid-single to low-double digits royalty rates on annual net sales. Seems like investors are only pricing doom and gloom and have not factored this value in current share prices. Seems fundamentally undervalued and unloved for understandable reasons tho considering Pxss poor management. | compoundinge | |
27/6/2018 17:06 | Being able to buy at the current share price is something like ethically correct stealing money from the blind. Wish I had more funds. Alas, I have to diversify and can not put any more money into it. Choices. | greedfear | |
27/6/2018 15:24 | good move jay ...I think! Clearly till the end game plays out we are all in the dark but I'm inclined to the view that 10p plus may be the reward here. | meijiman | |
27/6/2018 15:03 | PICKED UP SOME MORE TODAY.... | jayj4u | |
27/6/2018 15:03 | Great find timbo -very useful. | meijiman | |
27/6/2018 14:23 | I have just been browsing through the latest Corvus Pharmaceuticals Annual Report and came across further details of the agreement they have with Vernalis on CPI-444 The annual report can be downloaded here: The scope and size of the milestone payments and the royalties are quite a bit bigger than I had first thought (see abstract below) | timbo003 | |
27/6/2018 09:22 | a top-up at 6.1p.. in anticipation. At these prices the company is valued at 30million when they have 26+ million sitting in cash, not to mention the IP they hold. USA closure and supplier related settlement have largely been settled. Seems the downside risk are more than covered at these prices. What do u think? | compoundinge | |
27/6/2018 00:22 | LONDON, June 26, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP.L), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases, announces that all resolutions proposed at the General Meeting held today were duly passed on a poll So all is in place for a takeover in shares now. We’ll know very soon. | greedfear | |
25/6/2018 16:46 | The retrace is very low volume. Exactly the kind of games one would expect an interested party to play. I'm not worried and expecting news (very) soon. | greedfear | |
25/6/2018 15:41 | Notice the price coming back down to more realistic levels since I pointed out the rise in share price was far too optimistic . Think 3 to 5p is where this should be given the likelihood of the cash position falling on redundancies etc and any sale not likely to raise much . No matter how much he some people try ramping it the reality is it's only worth what someone will pay which is likely not much more than the cash position given the high burn rate . | bones698 | |
25/6/2018 15:30 | Tomorrow Verona's shareholders will vote about the new shares. Once approved, nothing standing in the way to make an offer in shares for VER. News this week? | greedfear | |
21/6/2018 18:46 | Spot on.....well said both | ffp | |
21/6/2018 18:00 | absolutely | bountyhunter | |
21/6/2018 17:03 | Its only worth what someone is prepared to pay full stop! Cudmore please call Warren Buffett and he will help you understand the fundamentals of investment. Overt ramping of a share in the mire does you no credit. This was actually a decent company wrecked by in inept and incompetent executive team and now the vultures hover over the remaining flesh. | catch007 | |
21/6/2018 10:11 | my guess is that it will be sold off in pieces as no-one will want the bad bits! (Must admit I don't hold these any more and am still a bit miffed with the significant loss in percentage terms that I made on this bag of ...biotech;) | bountyhunter | |
21/6/2018 09:33 | Nobby Come back and thank me when the RNS drops regarding the takeover price......multiples of where we are this morning.....trust me! | cudmore | |
20/6/2018 20:33 | Yes cud please tell me all the shares you are pumping because you are such a guru they are all bound to go up! TIA Nobby | nobbygnome | |
20/6/2018 20:15 | no need for any research , just buy every share you ramp as they are all getting taken over or going up 100% on news. Easy ! | arab3 | |
20/6/2018 20:05 | Arab Have you not done your research here? Tut tut! | cudmore | |
20/6/2018 19:50 | cudmore 20 Jun '18 - 08:47 - 1989 of 1993 0 1 0 Takeover news imminent.....get in before the herd arrives!!! fact ? | arab3 | |
20/6/2018 19:10 | QS99 Not ramping......just stating facts. Hope you’re fully loaded in IMM and VAL!!! Huge news coming from both of those very very soon, hence the rises today. | cudmore |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions